Published • loading... • Updated
Mpox vaccine trial in pregnant and post-partum individuals: PregInPoxVac maternal protocol now published
Summary by Penta
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Mpox vaccine trial in pregnant and post-partum individuals: PregInPoxVac maternal protocol now published
Following closely on the publication of the PregInPoxVac children's protocol, the PregInPoxVac maternal protocol paper has now been published in BMJ Open. The paper outlines the design of a Phase III, open-label trial evaluating the safety, reactogenicity, and immune responses of two-dose Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine regimens in 359 pregnant individuals aged 16
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
